Kathrin E. Witzke
Bochum, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: December 09, 2025
Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: January 06, 2023
Plasma Proteomics Enable Differentiation of Lung Adenocarcinoma from Chronic Obstructive Pulmonary Disease (COPD).
Journal: International journal of molecular sciences
Published: July 27, 2022
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer.
Journal: International journal of cancer
Published: December 15, 2021
Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer.
Journal: Journal of cellular and molecular medicine
Published: May 31, 2021
Application of Label-Free Proteomics for Quantitative Analysis of Urothelial Carcinoma and Cystitis Tissue.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 05, 2021
Urachal Cancer: an update of current molecular findings
Journal: Der Pathologe
Published: November 10, 2019
Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer.
Journal: The American journal of pathology
Published: August 24, 2018
Quantitative Secretome Analysis of Activated Jurkat Cells Using Click Chemistry-Based Enrichment of Secreted Glycoproteins.
Journal: Journal of proteome research
Published: October 05, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026